Results 61 to 70 of about 477,894 (133)

Management of Drug Interactions with Inducers: Onset and Disappearance of Induction on Cytochrome P450 3A4 and Uridine Diphosphate Glucuronosyltransferase 1A1 Substrates. [PDF]

Eur J Drug Metab Pharmacokinet, 2023
Bettonte S, Berton M, Stader F, Battegay M, Marzolini C.   +4 more
europepmc   +1 more source

Multidomain Model for Optic Nerve Potassium Clearance: Roles of Glial Cells and Perivascular Spaces [PDF]

arXiv
The accumulation of potassium in the extracellular space surrounding nerve cells is a fundamental aspect of biophysics that has garnered significant attention in recent research. This phenomenon holds implications for various neurological conditions, including spreading depression, migraine, certain types of epilepsy, and potentially, learning ...
arxiv  

Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic. [PDF]

Pediatr Infect Dis J, 2023
Denoeud-Ndam L, Stecker C, Andifasi P, Mushavi A, Maphosa T, Zondo M, Murandu M, Gombakomba G, Katirayi L, Mungati M, Bailey R, Weber R, Rivadeneira E, Hrapcak S.   +13 more
europepmc   +1 more source

The protective role of raltegravir in experimental acute lung injury in vitro and in vivo. [PDF]

Braz J Med Biol Res, 2022
Xu Z, Ren R, Jiang W.
europepmc   +1 more source

Obesity Modifies the Relationship Between Raltegravir and Dolutegravir Hair Concentrations and Body Weight Gain in Women Living with HIV. [PDF]

AIDS Res Hum Retroviruses, 2023
Lahiri CD, Mehta CC, Sykes C, Weiser SD, Palella F, Lake JE, Mellors JW, Gustafson D, French AL, Adimora AA, Konkle-Parker D, Sharma A, Bolivar H, Kassaye SG, Rubin LH, Alvarez JA, Golub ET, Ofotokun I, Sheth AN.   +18 more
europepmc   +1 more source

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. [PDF]

J Acquir Immune Defic Syndr, 2022
Coutinho CM, Warshaw MG, Duarte G, Stek A, Violari A, Hofer CB, Deville JG, Ngocho JS, Pilotto JH, Correa MD, Shapiro DE, Fuller TL, Chakhtoura N, Mirochnick M, João EC.   +14 more
europepmc   +1 more source

Relationship between raltegravir trough plasma concentration and virologic response and the impact of therapeutic drug monitoring during pregnancy. [PDF]

Int J STD AIDS, 2023
Carvalho S, Sheehan NL, Valois S, Kakkar F, Boucher M, Ferreira E, Boucoiran I.   +6 more
europepmc   +1 more source

Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. [PDF]

Pharmacogenomics J, 2023
Gurjar R, Dickinson L, Carr D, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, De Castro N, Fätkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Schwimmer C, Raffi F, Boffito M, NEAT001/ANRS143 Study Group.   +16 more
europepmc   +1 more source

Monitoring SARS-CoV-2 Viral Load and CD4+ T-cell Count After ART in a Patient Diagnosed With AIDS Following SARS-CoV-2 Infection: A Case Report. [PDF]

Cureus, 2023
Umekage Y, Hatayama M, Yagita A, Nitanai K, Yanada H, Shigaki R, Minami Y, Sasaki T.   +7 more
europepmc   +1 more source

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing. [PDF]

J Mol Model, 2023
Mohamed EAR, Abdel-Rahman IM, Zaki MEA, Al-Khdhairawi A, Abdelhamid MM, Alqaisi AM, Rahim LBA, Abu-Hussein B, El-Sheikh AAK, Abdelwahab SF, Hassan HA.   +10 more
europepmc   +1 more source